Why the study?
Does increased glutaraldehyde cross-linking of bioprosthetic heart valves reduce immunogenicity and calcification?
Does increased glutaraldehyde cross-linking of bioprosthetic heart valves reduce immunogenicity and calcification?
Increased cross-linking of bioprosthetic heart valve tissue may be necessary to mitigate immune responses and subsequent calcification.
Low-glutaraldehyde bioprostheses may still elicit humoral responses; leaves open whether alternative crosslinking improves durability.
In an attempt to avoid the destructive process of bioprosthetic heart-valve calcification associated with the use of glutaraldehyde, valves are today prepared using low concentrations of the crosslinking reagent. In this review, we summarize our findings and those of others that confirm that the immunogenicity of such tissue is not sufficiently masked and that a defined humoral response is indeed mounted against a repertoire of antigens unrelated to those associated with vascularized and noncross-linked xenograft organs. We demonstrate the need for increased cross-linking of tissue to satisfactorily mitigate that response; furthermore, we examine the impact of increased cross-link density on the macrophage as antigen presenting cell with respect to its involvement in both tissue erosion and pannus overgrowth. Finally we present evidence for a role of circulating antibodies in bioprosthesis calcification.
No takes yet. Share an insight, caveat, or question.
Human et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: